BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhattacharjee G, Gohil N, Khambhati K, Mani I, Maurya R, Karapurkar JK, Gohil J, Chu DT, Vu-Thi H, Alzahrani KJ, Show PL, Rawal RM, Ramakrishna S, Singh V. Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications. J Control Release 2022:S0168-3659(22)00080-3. [PMID: 35149141 DOI: 10.1016/j.jconrel.2022.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Maurya R, Gohil N, Nixon S, Kumar N, Noronha SB, Dhali D, Trabelsi H, Alzahrani KJ, Reshamwala SMS, Kumar Awasthi M, Ramakrishna S, Singh V. Rewiring of metabolic pathways in yeasts for sustainable production of biofuels. Bioresour Technol 2023;:128668. [PMID: 36693507 DOI: 10.1016/j.biortech.2023.128668] [Reference Citation Analysis]
2 Madhi ZS, Shallan MA, Almaamuri AM, Alhussainy AA, Al- Salih SSS, Raheem AK, Alwan HJ, Jalil AT. Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103948] [Reference Citation Analysis]
3 Maurya R, Bhattacharjee G, Gohil N, Khambhati K, Shakhreliya S, Bhatnagar A, Singh P, Ramakrishna S, Singh V. Low density lipoprotein receptor endocytosis in cardiovascular disease and the factors affecting LDL levels. Prog Mol Biol Transl Sci 2023;194:333-45. [PMID: 36631197 DOI: 10.1016/bs.pmbts.2022.09.010] [Reference Citation Analysis]
4 Chira S, Nutu A, Isacescu E, Bica C, Pop L, Ciocan C, Berindan-neagoe I. Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research. Cells 2022;11:2781. [DOI: 10.3390/cells11182781] [Reference Citation Analysis]
5 Verma NV, Shukla M, Kulkarni R, Srivastava K, Claudic B, Savara J, Joseph Mathew M, Maurya R, Bhattacharjee G, Singh V, Pandya A. Emerging Extraction and Diagnostic Tools for Detection of Plant Pathogens: Recent Trends, Challenges, and Future Scope. ACS Agric Sci Technol 2022. [DOI: 10.1021/acsagscitech.2c00150] [Reference Citation Analysis]
6 Khambhati K, Bhattacharjee G, Gohil N, Dhanoa GK, Sagona AP, Mani I, Bui NL, Chu D, Karapurkar JK, Jang SH, Chung HY, Maurya R, Alzahrani KJ, Ramakrishna S, Singh V. Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Luo N, Zhong W, Li J, Zhai Z, Lu J, Dong R. Targeted activation of HNF4α/HGF1/FOXA2 reverses hepatic fibrosis via exosome-mediated delivery of CRISPR/dCas9-SAM system. Nanomedicine (Lond) 2022;17:1411-27. [PMID: 36326013 DOI: 10.2217/nnm-2022-0083] [Reference Citation Analysis]
8 Gupta A, Singh V, Mani I. Dysbiosis of human microbiome and infectious diseases. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.06.016] [Reference Citation Analysis]